Skip to main content

Table 3 Comparison of t–AUC between Nomogram and AJCC Staging system

From: Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)

 

t–AUC (Nomogram)

t–AUC (AJCC Stage)

P–value

6–month

0.766

0.546

< 0.001

12–month

0.715

0.554

< 0.001

18–month

0.703

0.557

< 0.001

  1. Abbreviations: AUC Area under the curve, AJCC American Joint Committee on Cancer